The importance of drug delivery technology grows ever more acute; commercial and industry interest is continuing to build. The benefits to patients can be seen in improved medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes, bringing new therapies to the market that would, previously, have been impossible to administer.
In
670+ information-packed pages
, this new richly-detailed report
Drug Delivery: Surveying the global competitive landscape 2012
provides the most comprehensive review of the sector and examines the
competitive drug delivery landscape with analysis of 112 key companies,
including large/ small from multinationals to specialist development and
technology businesses. All major technology areas such as Controlled-release,
Nucleic acid, Nano-enabled and Targeted delivery are covered.
